{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:38:58Z","timestamp":1791211138522,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T00:00:00Z","timestamp":1385078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00401-013-1213-7","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T03:44:43Z","timestamp":1385005483000},"page":"189-201","source":"Crossref","is-referenced-by-count":100,"title":["Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group"],"prefix":"10.1007","volume":"127","author":[{"given":"Nicholas G.","family":"Gottardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan R.","family":"Hansford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline P.","family":"McGlade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Alvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bourdeaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Jae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Clay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine H.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Dallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Downie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Doz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raelene","family":"Endersby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Hassall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary L.","family":"Hii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T. W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reimar","family":"Junckerstorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"Kellie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi S.","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Laughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"McCowage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Northcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Pizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Pomeroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Remke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles W.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schoep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anang A.","family":"Shelat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton F.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Wainwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Walwyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,22]]},"reference":[{"issue":"11","key":"1213_CR1","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1200\/JCO.2010.28.5148","volume":"29","author":"YJ Cho","year":"2011","unstructured":"Cho YJ, Tsherniak A, Tamayo P et al (2011) Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 29(11):1424\u20131430","journal-title":"J Clin Oncol"},{"issue":"2","key":"1213_CR2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncr.10189","volume":"94","author":"CG Eberhart","year":"2002","unstructured":"Eberhart CG, Kepner JL, Goldthwaite PT et al (2002) Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 94(2):552\u2013560","journal-title":"Cancer"},{"issue":"3","key":"1213_CR3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-010-0726-6","volume":"120","author":"DW Ellison","year":"2010","unstructured":"Ellison DW (2010) Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease. Acta Neuropathol 120(3):305\u2013316","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1213_CR4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-011-0800-8","volume":"121","author":"DW Ellison","year":"2011","unstructured":"Ellison DW, Dalton J, Kocak M et al (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH\/WNT molecular subgroups. Acta Neuropathol 121(3):381\u2013396","journal-title":"Acta Neuropathol"},{"issue":"11","key":"1213_CR5","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1200\/JCO.2010.30.2810","volume":"29","author":"DW Ellison","year":"2011","unstructured":"Ellison DW, Kocak M, Dalton J et al (2011) Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol 29(11):1400\u20131407","journal-title":"J Clin Oncol"},{"issue":"31","key":"1213_CR6","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1200\/JCO.2005.01.5479","volume":"23","author":"DW Ellison","year":"2005","unstructured":"Ellison DW, Onilude OE, Lindsey JC et al (2005) Beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children\u2019s Cancer Study Group Brain Tumour Committee. J Clin Oncol 23(31):7951\u20137957","journal-title":"J Clin Oncol"},{"issue":"1","key":"1213_CR7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/path.2514","volume":"218","author":"S Fattet","year":"2009","unstructured":"Fattet S, Haberler C, Legoix P et al (2009) Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics. J Pathol 218(1):86\u201394","journal-title":"J Pathol"},{"issue":"10","key":"1213_CR8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","volume":"7","author":"A Gajjar","year":"2006","unstructured":"Gajjar A, Chintagumpala M, Ashley D et al (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7(10):813\u2013820","journal-title":"Lancet Oncol"},{"issue":"4","key":"1213_CR9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/pbc.22378","volume":"54","author":"A Gajjar","year":"2010","unstructured":"Gajjar A, Pizer B (2010) Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors. Pediatr Blood Cancer 54(4):649\u2013651","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"1213_CR10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00401-013-1126-5","volume":"125","author":"V Hovestadt","year":"2013","unstructured":"Hovestadt V, Remke M, Kool M et al (2013) Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol 125(6):913\u2013916","journal-title":"Acta Neuropathol"},{"issue":"21","key":"1213_CR11","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1200\/JCO.2011.40.2792","volume":"30","author":"RI Jakacki","year":"2012","unstructured":"Jakacki RI, Burger PC, Zhou T et al (2012) Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children\u2019s Oncology Group Phase I\/II study. J Clin Oncol 30(21):2648\u20132653","journal-title":"J Clin Oncol"},{"issue":"7409","key":"1213_CR12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature11284","volume":"488","author":"DT Jones","year":"2012","unstructured":"Jones DT, Jager N, Kool M et al (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature 488(7409):100\u2013105","journal-title":"Nature"},{"issue":"8","key":"1213_CR13","doi-asserted-by":"crossref","first-page":"e3088","DOI":"10.1371\/journal.pone.0003088","volume":"3","author":"M Kool","year":"2008","unstructured":"Kool M, Koster J, Bunt J et al (2008) Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS ONE 3(8):e3088","journal-title":"PLoS ONE"},{"issue":"2","key":"1213_CR14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","volume":"46","author":"RD Kortmann","year":"2000","unstructured":"Kortmann RD, Kuhl J, Timmermann B et al (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT \u201891. Int J Radiat Oncol Biol Phys 46(2):269\u2013279","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"26","key":"1213_CR15","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2011.39.8719","volume":"30","author":"B Lannering","year":"2012","unstructured":"Lannering B, Rutkowski S, Doz F et al (2012) Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol 30(26):3187\u20133193","journal-title":"J Clin Oncol"},{"issue":"7","key":"1213_CR16","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2008.13.5293","volume":"26","author":"SJ Laughton","year":"2008","unstructured":"Laughton SJ, Merchant TE, Sklar CA et al (2008) Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol 26(7):1112\u20131118","journal-title":"J Clin Oncol"},{"issue":"2","key":"1213_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97\u2013109","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1213_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1037\/0894-4105.22.2.159","volume":"22","author":"DJ Mabbott","year":"2008","unstructured":"Mabbott DJ, Penkman L, Witol A, Strother D, Bouffet E (2008) Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 22(2):159\u2013168","journal-title":"Neuropsychology"},{"issue":"10","key":"1213_CR19","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1200\/JCO.2005.01.158","volume":"23","author":"DJ Mabbott","year":"2005","unstructured":"Mabbott DJ, Spiegler BJ, Greenberg ML et al (2005) Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol 23(10):2256\u20132263","journal-title":"J Clin Oncol"},{"issue":"2","key":"1213_CR20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/pbc.24225","volume":"60","author":"M Massimino","year":"2013","unstructured":"Massimino M, Antonelli M, Gandola L et al (2013) Histological variants of medulloblastoma are the most powerful clinical prognostic indicators. Pediatr Blood Cancer 60(2):210\u2013216","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"1213_CR21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jnen\/62.6.627","volume":"62","author":"CS McManamy","year":"2003","unstructured":"McManamy CS, Lamont JM, Taylor RE et al (2003) Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. J Neuropathol Exp Neurol 62(6):627\u2013632","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1213_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijc.28330","volume":"134","author":"LA Milla","year":"2014","unstructured":"Milla LA, Arros A, Espinoza N et al (2014) Neogenin1 is a sonic hedgehog target in medulloblastoma and is necessary for cell cycle progression. Int J Cancer 134(1):21\u201331","journal-title":"Int J Cancer"},{"issue":"6","key":"1213_CR23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/clpt.2013.54","volume":"93","author":"PA Milligan","year":"2013","unstructured":"Milligan PA, Brown MJ, Marchant B et al (2013) Model-based drug development: a rational approach to efficiently accelerate drug development. Clin Pharmacol Ther 93(6):502\u2013514","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1213_CR24","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.1998.16.5.1723","volume":"16","author":"RK Mulhern","year":"1998","unstructured":"Mulhern RK, Kepner JL, Thomas PR et al (1998) Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 16(5):1723\u20131728","journal-title":"J Clin Oncol"},{"issue":"24","key":"1213_CR25","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1200\/JCO.2005.00.703","volume":"23","author":"RK Mulhern","year":"2005","unstructured":"Mulhern RK, Palmer SL, Merchant TE et al (2005) Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23(24):5511\u20135519","journal-title":"J Clin Oncol"},{"issue":"12","key":"1213_CR26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nrc3410","volume":"12","author":"PA Northcott","year":"2012","unstructured":"Northcott PA, Jones DT, Kool M et al (2012) Medulloblastomics: the end of the beginning. Nat Rev Cancer 12(12):818\u2013834","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1213_CR27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrneurol.2012.78","volume":"8","author":"PA Northcott","year":"2012","unstructured":"Northcott PA, Korshunov A, Pfister SM, Taylor MD (2012) The clinical implications of medulloblastoma subgroups. Nat Rev Neurol 8(6):340\u2013351","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"1213_CR28","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","volume":"29","author":"PA Northcott","year":"2011","unstructured":"Northcott PA, Korshunov A, Witt H et al (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29(11):1408\u20131414","journal-title":"J Clin Oncol"},{"issue":"7409","key":"1213_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature11327","volume":"488","author":"PA Northcott","year":"2012","unstructured":"Northcott PA, Shih DJ, Peacock J et al (2012) Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488(7409):49\u201356","journal-title":"Nature"},{"issue":"4","key":"1213_CR30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00401-011-0899-7","volume":"123","author":"PA Northcott","year":"2012","unstructured":"Northcott PA, Shih DJ, Remke M et al (2012) Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol 123(4):615\u2013626","journal-title":"Acta Neuropathol"},{"issue":"21","key":"1213_CR31","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1200\/JCO.2005.00.760","volume":"23","author":"V Oyharcabal-Bourden","year":"2005","unstructured":"Oyharcabal-Bourden V, Kalifa C, Gentet JC et al (2005) Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol 23(21):4726\u20134734","journal-title":"J Clin Oncol"},{"issue":"25","key":"1213_CR32","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","volume":"24","author":"RJ Packer","year":"2006","unstructured":"Packer RJ, Gajjar A, Vezina G et al (2006) Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24(25):4202\u20134208","journal-title":"J Clin Oncol"},{"issue":"7","key":"1213_CR33","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.1999.17.7.2127","volume":"17","author":"RJ Packer","year":"1999","unstructured":"Packer RJ, Goldwein J, Nicholson HS et al (1999) Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children\u2019s Cancer Group Study. J Clin Oncol 17(7):2127\u20132136","journal-title":"J Clin Oncol"},{"issue":"10","key":"1213_CR34","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneurol.2012.197","volume":"8","author":"RJ Packer","year":"2012","unstructured":"Packer RJ, Hoffman EP (2012) Neuro-oncology: understanding the molecular complexity of medulloblastoma. Nat Rev Neurol 8(10):539\u2013540","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1213_CR35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/neuonc\/nos267","volume":"15","author":"RJ Packer","year":"2013","unstructured":"Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A (2013) Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children\u2019s Oncology Group trial A9961. Neuro Oncol 15(1):97\u2013103","journal-title":"Neuro Oncol"},{"issue":"28","key":"1213_CR36","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1200\/JCO.2012.47.4775","volume":"31","author":"SL Palmer","year":"2013","unstructured":"Palmer SL, Armstrong C, Onar-Thomas A et al (2013) Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study. J Clin Oncol 31(28):3494\u20133500","journal-title":"J Clin Oncol"},{"issue":"6016","key":"1213_CR37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1126\/science.1198056","volume":"331","author":"DW Parsons","year":"2011","unstructured":"Parsons DW, Li M, Zhang X et al (2011) The genetic landscape of the childhood cancer medulloblastoma. Science 331(6016):435\u2013439","journal-title":"Science"},{"issue":"10","key":"1213_CR38","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1200\/JCO.2008.17.9432","volume":"27","author":"S Pfister","year":"2009","unstructured":"Pfister S, Remke M, Benner A et al (2009) Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 27(10):1627\u20131636","journal-title":"J Clin Oncol"},{"issue":"7409","key":"1213_CR39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11329","volume":"488","author":"TJ Pugh","year":"2012","unstructured":"Pugh TJ, Weeraratne SD, Archer TC et al (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488(7409):106\u2013110","journal-title":"Nature"},{"issue":"15","key":"1213_CR40","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1200\/JCO.2001.19.15.3470","volume":"19","author":"MD Ris","year":"2001","unstructured":"Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM (2001) Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children\u2019s Cancer Group study. J Clin Oncol 19(15):3470\u20133476","journal-title":"J Clin Oncol"},{"issue":"7409","key":"1213_CR41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature11213","volume":"488","author":"G Robinson","year":"2012","unstructured":"Robinson G, Parker M, Kranenburg TA et al (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488(7409):43\u201348","journal-title":"Nature"},{"issue":"10","key":"1213_CR42","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa042176","volume":"352","author":"S Rutkowski","year":"2005","unstructured":"Rutkowski S, Bode U, Deinlein F et al (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352(10):978\u2013986","journal-title":"N Engl J Med"},{"issue":"33","key":"1213_CR43","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1200\/JCO.2010.30.2299","volume":"28","author":"S Rutkowski","year":"2010","unstructured":"Rutkowski S, von Hoff K, Emser A et al (2010) Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol 28(33):4961\u20134968","journal-title":"J Clin Oncol"},{"issue":"4","key":"1213_CR44","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00401-011-0923-y","volume":"123","author":"SL Ryan","year":"2012","unstructured":"Ryan SL, Schwalbe EC, Cole M et al (2012) MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma. Acta Neuropathol 123(4):501\u2013513","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1213_CR45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00401-012-1077-2","volume":"125","author":"EC Schwalbe","year":"2013","unstructured":"Schwalbe EC, Williamson D, Lindsey JC et al (2013) DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol 125(3):359\u2013371","journal-title":"Acta Neuropathol"},{"issue":"11","key":"1213_CR46","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jocn.2012.04.009","volume":"19","author":"NR Smoll","year":"2012","unstructured":"Smoll NR, Drummond KJ (2012) The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children. J Clin Neurosci 19(11):1541\u20131544","journal-title":"J Clin Neurosci"},{"issue":"4","key":"1213_CR47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.2004.05.186","volume":"22","author":"BJ Spiegler","year":"2004","unstructured":"Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ (2004) Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 22(4):706\u2013713","journal-title":"J Clin Oncol"},{"issue":"9","key":"1213_CR48","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/cncr.21003","volume":"103","author":"U Tabori","year":"2005","unstructured":"Tabori U, Sung L, Hukin J et al (2005) Medulloblastoma in the second decade of life: a specific group with respect to toxicity and management: a Canadian Pediatric Brain Tumor Consortium Study. Cancer 103(9):1874\u20131880","journal-title":"Cancer"},{"issue":"4","key":"1213_CR49","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","volume":"123","author":"MD Taylor","year":"2012","unstructured":"Taylor MD, Northcott PA, Korshunov A et al (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123(4):465\u2013472","journal-title":"Acta Neuropathol"},{"issue":"8","key":"1213_CR50","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2003.05.116","volume":"21","author":"RE Taylor","year":"2003","unstructured":"Taylor RE, Bailey CC, Robinson K et al (2003) Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology\/United Kingdom Children\u2019s Cancer Study Group PNET-3 Study. J Clin Oncol 21(8):1581\u20131591","journal-title":"J Clin Oncol"},{"issue":"16","key":"1213_CR51","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1200\/JCO.2000.18.16.3004","volume":"18","author":"PR Thomas","year":"2000","unstructured":"Thomas PR, Deutsch M, Kepner JL et al (2000) Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18(16):3004\u20133011","journal-title":"J Clin Oncol"},{"issue":"12","key":"1213_CR52","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2005.04.4974","volume":"24","author":"MC Thompson","year":"2006","unstructured":"Thompson MC, Fuller C, Hogg TL et al (2006) Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24(12):1924\u20131931","journal-title":"J Clin Oncol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-013-1213-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-013-1213-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-013-1213-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T17:54:16Z","timestamp":1564854856000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-013-1213-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,22]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1213"],"URL":"https:\/\/doi.org\/10.1007\/s00401-013-1213-7","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,22]]}}}